Why atherosclerosis is far more than just clogged pipes

Beyond the grease trap

Think of your blood vessels as smooth copper plumbing. When water rushes through bends, it churns violently. In our bodies, this disturbed flow strips away protection, causing endothelial dysfunction, where the inner lining loses its healthy chemical shields. Yet heart disease is not simply a pipe collecting fatty sludge. In 2023, cardiovascular disease affected 626 million people worldwide, claiming 19.2 million lives. Cholesterol plays a part, but even when modern drugs lower blood fats, a stubborn danger often lingers. Scientists reviewing recent molecular studies found that blood vessel walls stage their own chaotic, multisystem battle.

Immune cells with long memories

Trouble begins when physical stress triggers sensors like PIEZO1 in the artery lining. This activates inflammatory signals, calling in white blood cells known as monocytes. Once inside the vessel wall, these cells mature into hungry macrophages that swallow up fatty particles. Instead of clearing the mess and standing down, these cells become trapped. Worse, they develop trained immunity: sustained epigenetic changes that keep their internal alarms firing permanently. The immune system essentially remembers the injury, continuously stoking local inflammation even if the original cholesterol danger drops.

Muscle cells that switch identities

The artery wall itself joins the chaos. Normal blood vessels rely on smooth muscle cells to flex and control pressure. However, tracking their genetic lineages revealed surprising behaviour: a small pool starts dividing uncontrollably, much like tumour cells. Some acquire oncogenic mutations such as KrasG12D, dodging normal cell death. These shapeshifters transform into fibromyocytes, cell types that churn out scar-like matrix instead of keeping the vessel flexible. A vast map of over 320,000 regulatory sites across human coronary arteries shows how these cells switch their entire molecular program.

Signals from the gut

The drama extends far beyond the heart. Microbes living in our digestive tract break down dietary nutrients to produce compounds like trimethylamine-N-oxide (TMAO). This chemical enters the bloodstream, making platelets twitchy and amplifying vessel inflammation. In an 18-year study, vegetarian adults with low TMAO levels had about a 22% lower relative risk of ischemic heart disease compared with meat eaters. Yet, this key caveat stands: lowering TMAO offers only partial protection. None of our current therapies directly fix the tangled web of cellular changes inside the vessel wall, leaving substantial residual disease behind.

What we still do not know

Puzzles remain before treatments can safely target these local pathways. Human plaques show specific immune features that traditional mouse models lack, especially among immune T cells. Researchers still debate whether these human-specific traits reflect fundamental biological differences between species, or simply older, more advanced stages of disease. Delivering drugs that can quietly disarm trained immune memories and halt rogue muscle cells without disrupting the rest of the body remains an unsolved challenge.